Kisspeptin-10 Peptide For Sale

Kisspeptin-10 is a peptide fragment derived from the full-length Kisspeptin (also referred to as Kisspeptin-54 or Metastin). Specifically, Kisspeptin-10 is a fragment containing the 45-54 sequence from the larger parent molecule. Research into this peptide has suggested that the compound may act as a mediator of endocrine signaling between various endocrine cells.

Originating from the KISS1 gene, which is thought to play a critical role in reproductive cell signaling and physiology, Kisspeptin-10 is particularly interesting to researchers for its potential to influence the secretion of gonadotropin-releasing hormone (GnRH). This, in turn, may affect the release of other reproductive hormones from cells with receptors for GnRH. In addition, researchers posit that the compound may potentially impact the development and regulation of blood vessels and renal function, and some studies have suggested it may mitigate cancer cell proliferation and metastasis.^[1]

Specifications

Molecular Weight: 1302.4 g/mol

Molecular Formula: C₆₃H₈₃N₁₇O₁₄

Sequence: YNWNSFGLRF

Other Known Titles: KISS-1, Protein KISS-1, Metastin, Kp-10 peptide

Kisspeptin-10 Research

Kisspeptin-10 and Gonadotropin-Releasing Hormone Signalling
Researchers have posited that Kisspeptin-10 may affect the hypothalamic-pituitary-gonadal axis. This axis consists of hypothalamic cells producing GnRH, which in turn interacts with pituitary cells, possibly increasing the rate at which LH and FSH are released. Studies suggest that this release may induce a ~3x increase in testosterone synthesis by male gonadal cells.^[2] Kisspeptin appears to act at the top of the hypothalamic-pituitary-gonadal axis, interacting with the hypothalamic cells, which produce GnRH.

Researchers suggest that similar to its parent molecule (Kisspeptin-54), Kisspeptin-10 may present the possibility of some biological activity towards GPR54 receptors, also called KISS1 receptors (KISS1Rs).^[3] These smaller peptides have been posited to bind with a low affinity to the GPR54 receptors and possibly stimulate calcium mobilization, arachidonic acid release, and extracellular signal-regulated protein kinase 1 (ERK1), ERK2, and p38 MAP kinase phosphorylation. These events may depolarize the GnRH neurons and modulate GnRH release. However, this modulation may not necessarily be positive.

While Kisspeptin-10 may initially upregulate the production of GnRH, data from KP-54 studies suggests that repeated exposure to Kisspeptin-10 may potentially desensitize KISS1R receptors. This desensitization might reduce the receptors’ responsiveness to endogenous kisspeptins, which may contribute to the suppression of the hypothalamic-pituitary-gonadal axis.

Observations by relevant scientists indicate that frequent exposure to kisspeptin analogs like KP-54 may diminish luteinizing hormone responses over time and nearly abolish follicle-stimulating hormone responsiveness within a short period. This phenomenon might be attributed to receptor downregulation or internalization, although the exact mechanisms remain to be fully elucidated.^[4]

Kisspeptin-10 and Energy Metabolism
Researchers posit that there may be a “novel role of kisspeptin neurons as active players within the neuronal circuits that govern energy balance […], offering [data supportive] of a bidirectional role of these neurons as a nexus between metabolism and reproduction.” ^[5] Indeed, Kisspeptin-10 interacts with hypothalamic cells, and the hypothalamus is thought to be a brain region involved in the regulation of hunger hormone signals. For example, recent experimental observations suggest that Kisspeptin-10 might influence the expression of genes associated with neuropeptide Y (NPY) and brain-derived neurotrophic factor (BDNF).^[6]

In this context, NPY is a neurotransmitter that may play a crucial role in appetite regulation and energy balance. At the same time, BDNF is a protein that may be essential for neuron survival and synaptic plasticity. Moreover, Kisspeptin-10 is hypothesized to potentially impact the concentrations of certain neurotransmitters and their metabolites within hypothalamic neurons, specifically in a cell line referred to as Hypo-E22 cells derived from the hypothalamus. Neurotransmitters that might be impacted include dopamine, norepinephrine, and serotonin (also referred to as 5-hydroxytryptamine or 5-HT).

Their respective metabolites of interest are dihydroxyphenylacetic acid (DOPAC), a primary metabolite of dopamine, and hydroxy indole acetic acid (5-HIAA), the main metabolite of serotonin. Experimental findings imply that Hypo-E22 cells may respond to Kisspeptin-10 by increasing the expression of the NPY gene. This may potentially support the production of neuropeptide Y and may increase satiety following caloric intake.

Kisspeptin-10 and Cancer Cells
Kisspeptin has been suggested to influence the malignancy of melanoma cells by interacting with the KISS1 receptors. This assumption has been attributed to the peptide’s potential to impact the migration of cancerous cells by reducing the adhesive capacity of these cells. Cancer cell cultures taken from tissues such as the breast, urinary bladder, gastrointestinal tract, prostate, pancreas, ovaries, epidermis, and thyroid tissue of research models all appeared to exhibit reduced expression of Kisspeptin. This suggests that exposure to the peptide may support environments for the metastasis of malignant cells. Research has also linked the levels of endogenous Kisspeptin and melatonin production to sunlight.^[7] Upon extensive sun exposure, murine models were assessed, reporting excess Kisspeptin and melatonin production.

Kisspeptin-10 and Behavioral Regulation
Hormonal release cycles influence reproductive activities, energy levels, and certain behavioral factors. Researchers posit that Kisspeptin levels may affect reproduction and energy homeostasis. Recent studies have observed better-supported limbic brain activity, such as increased reward-seeking behavior and enthusiasm, upon increased Kisspeptin exposure.^[8] Research in this area is ongoing.

Kisspeptin-10 and Kidney, Heart
Other than its potential mitigatory role in tumor metastasis, Kisspeptin appears to have regulatory capacity within the kidney and heart. Kisspeptin-10 and its receptors appear to be expressed in renal tissues, and studies have reported that the Kiss-1 receptor knockouts fail to regulate glomerular development.^[9] Scientists report that “Kisspeptins and kisspeptin receptors are altered in the kidney tissues of chronic renal impairment, raising the possibility of their pathophysiological roles in chronic renal failure.”

Furthermore, Kisspeptin has been observed to control vasoconstriction and sometimes cardiac output under specific laboratory conditions.^[10] Such regulation may be related to Kisspeptin’s potential to impact vascular development and response to injury, the exact mechanism of which remains to be elucidated.

Kisspeptin-10 and Neuroprotection
Kisspeptin-10 may potentially protect nerve cells in laboratory settings by mitigating the negative potential associated with α-synuclein (α-syn), a protein implicated in neurodegenerative conditions.^[11] In experiments using cholinergic-like neurons engineered to overexpress either wild-type or mutant forms of α-syn, Kisspeptin-10 apparently reduced the rate of apoptosis. It was observed to mitigate mitochondrial depolarization induced by excessive α-syn. Computational models have posited that Kisspeptin-10 might directly interact with α-syn by fitting into binding pockets located at the protein’s C-terminal region.

This possible direct binding might inhibit the formation of toxic α-syn aggregates, thereby reducing neurotoxicity. Interestingly, Kisspeptin-10’s neuroprotective actions seem to be independent of its typical receptor, GPR54. The presence of a GPR54 antagonist did not diminish Kisspeptin-10’s protective actions, suggesting that Kisspeptin-10 might exert its actions through a receptor-independent mechanism.

Furthermore, Kisspeptin-10 was observed to decrease the immunoreactivity of both α-syn and choline acetyltransferase (ChAT) in neurons overexpressing α-syn. This finding may imply that Kisspeptin-10 may influence the expression levels or aggregation state of α-syn and affect cholinergic neuronal function.